For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous and about 40% do not seroconvert.

类风湿因子（rheumatoid factor，RF）可分为IgM、IgA、IgG、IgD、IgE五型（注：在临床内科学中描述为四型，没有IgD型；但在实验室诊断学中描述为5型），是类风湿关节炎血清中针对IgG FC片段上抗原表位的一类自身抗体，类风湿因子阳性患者较多伴有关节外表现，如皮下结节及血管炎等。IgM型RF阳性率为60%-78%。

类风湿因子（rheumatoid factor，RF）可分为IgM、IgA、IgG、IgD、IgE五型（注：在临床内科学中描述为四型，没有IgD型；但在实验室诊断学中描述为5型），是类风湿关节炎血清中针对IgG FC片段上抗原表位的一类自身抗体，类风湿因子阳性患者较多伴有关节外表现，如皮下结节及血管炎等。IgM型RF阳性率为60%-78%。

Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce that it has submitted the Clinical Study Report to the U.S. Food ...

Fintel reports that on January 13, 2025, JP Morgan upgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from ...

The reagents are meant for measuring aCL and aβ2GP1 antibody levels in human serum to aid the diagnosis of primary and secondary APS.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Werfen today announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the Aptiva® ...

Patients with systemic lupus erythematosus (SLE) who test positive for antiphospholipid antibodies (aPLs) are at a significantly higher risk of developing diffuse alveolar hemorrhage (DAH), according ...